MedTrace Logo

GDM Post Partum Screening

NCT03946631 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2022-12-14

No results posted yet for this study

Summary

Immediate postpartum screening for diabetes mellitus in women with gestational diabetes

The objective of this study is to determine if screening for type 2 diabetes can be done 24 hours after delivery, versus 6-12 weeks postpartum, in recently delivered women having been diagnosed with gestational diabetes requiring medication therapy in the antecedent pregnancy.

Conditions

  • Diabetes
  • Gestational Diabetes
  • Diabetes Mellitus, Type 2

Interventions

DIAGNOSTIC_TEST

2 hour glucose tolerance test using 75g glucose drink

intervention is a 2 hour glucose tolerance test. Involves oral intake of a 75g glucose drink followed by using point of care testing. Glucose drink is taken after at least 6 hours of fasting. Fingerstick blood glucose testing done at three time points: fasting, one hour post drink and two hours post drink.

Sponsors & Collaborators

  • Banner University Medical Center

    collaborator OTHER

  • Pediatrix

    lead OTHER

Principal Investigators

  • Laura Wilkes · Banner University Medical Center

  • Kisti Fuller, MD · Phoenix Perinatal Associates, Mednax

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-20
Primary Completion
2022-10-21
Completion
2022-10-21

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03946631 on ClinicalTrials.gov